Photocure ASA

Photocure ASA Aktien

53,90
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to license partners, pharmaceutical wholesalers, and hospitals. Photocure ASA was founded in 1997 and is headquartered in Oslo, Norway. Læs mere
Kr. 1,5B Markedsværdi (Mcap)
Kr. 501M Omsætning
Drug Manufacturers - Specialty & Generic Industri
Norge Handles på børsen
photocure.com Hjemmeside
Sundhed Sektor